CHDAalso facilitates theevaluation process, convenes the initial group of essentialpatent (andpatentapplication) holders and processes their deliberations to concludetermsof a jointlicense.
On Wednesday, ViiV Healthcare a joint venture of GlaxoSmithKline, Pfizer, and Shionogi announced it would grant a voluntary license to the Medicines Patent Pool to enable low-cost supply of a key pediatric HIV medicine in the 118 countries in which 98.7% of all HIV-positive children reside.